BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 137247)

  • 1. Serum dehydroepiandrosterone sulfate in premature infants and infants with intrauterine growth retardation.
    Turnipseed MR; Bentley K; Reynolds JW
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1219-25. PubMed ID: 137247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in fetal rhesus monkey plasma dehydroepiandrosterone sulfate: relationship to gestational age, adrenal weight and preterm delivery.
    Serón-Ferré M; Taylor NF; Rotten D; Koritnik DR; Jaffe RB
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1173-8. PubMed ID: 6226675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cortisol and dehydroepiandrosterone sulfate responses to adrenocorticotropin stimulation in premature infants.
    Noguchi A; Reynolds JW
    Pediatr Res; 1978 Nov; 12(11):1057-61. PubMed ID: 214744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of fetal zone function in the infant rhesus monkey adrenal gland.
    Serón-Ferré M; Hess DL; Lindholm U; Jaffe RB
    J Clin Endocrinol Metab; 1986 Mar; 62(3):460-5. PubMed ID: 2935553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal cortical function in the postmature fetus and newborn infant.
    Barnhart BJ; Carlson CV; Reynolds JW
    Pediatr Res; 1980 Dec; 14(12):1367-9. PubMed ID: 6259578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of intrauterine fetal growth retardation by prolongation of dehydroepiandrosterone sulfate (DHAS) half-life after DHAS loading.
    Rabe T; Runnebaum B; Koeppen U; Widmaier G; Kubli F
    Eur J Obstet Gynecol Reprod Biol; 1982 May; 13(3):145-58. PubMed ID: 6212274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feto-placental steroid metabolism in growth retarded human fetuses.
    Reynolds JW; Barnhart BJ; Carlson CV
    Pediatr Res; 1986 Feb; 20(2):166-8. PubMed ID: 2935778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of the adrenal androgen, dehydroepiandrosterone sulfate, during normal infancy, childhood, and adolescence, in sick infants, and in children with endocrinologic abnormalities.
    Reiter EO; Fuldauer VG; Root AW
    J Pediatr; 1977 May; 90(5):766-70. PubMed ID: 140222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production.
    de Peretti E; Forest MG
    J Clin Endocrinol Metab; 1978 Sep; 47(3):572-7. PubMed ID: 162515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of intrauterine fetal growth retardation by DHAS half-life.
    Rabe T; Hösch R; Kiesel L; Runnebaum B; Keller PJ; Kubli F
    Eur J Obstet Gynecol Reprod Biol; 1986 Jun; 22(1-2):41-51. PubMed ID: 2941326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of maternal adrenal dehydroepiandrosterone and dehydroepiandrosterone sulfate production by estrogen during baboon pregnancy.
    Albrecht ED; Pepe GJ
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3201-8. PubMed ID: 7593427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
    Schiebinger RJ; Chrousos GP; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 Jan; 62(1):202-9. PubMed ID: 2999177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of prostaglandin E and F 2 alpha in healthy newborn infants and in infants with hyaline membrane disease.
    Csaba IF; Sulyok E; Ertl T
    Acta Paediatr Acad Sci Hung; 1979; 20(2-3):193-8. PubMed ID: 546017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal adrenal steroidogenesis in growth-retarded newborn infants.
    Parker CR; Buchina ES; Barefoot TK
    Pediatr Res; 1994 Jun; 35(6):633-6. PubMed ID: 7936810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical serum DHAS and total oestriol in relation to gestational age and mode of delivery.
    Noguchi A; Turnipseed MR; Bentley K; Reynolds JW
    Acta Endocrinol (Copenh); 1980 Sep; 95(1):97-100. PubMed ID: 6450504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of intrauterine fetal growth retardation (IUGR) and placental insufficiency by a dehydroepiandrosterone sulfate (DHAS) loading test.
    Rabe T; Hösch R; Runnebaum B
    Biol Res Pregnancy Perinatol; 1983; 4(3):130-6. PubMed ID: 6226324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retarded fetal growth patterns and early neonatal mortality in a Mexico City population.
    Balcazar H; Haas JD
    Bull Pan Am Health Organ; 1991; 25(1):55-63. PubMed ID: 2054553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum DHAS in the maternal-fetoplacental system during the 28th-40th weeks of pregnancy.
    Hercz P; Ungár L; Siklós P; Farquharson RG
    Eur J Obstet Gynecol Reprod Biol; 1988 Sep; 29(1):1-5. PubMed ID: 2976004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of adrenal steroids and their precursors as a measure of maturity of adrenocortical function in very premature newborns.
    Nykänen P; Heinonen K; Riepe FG; Sippell WG; Voutilainen R
    Horm Res Paediatr; 2010; 74(5):358-64. PubMed ID: 20606393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased morbidity in severe early intrauterine growth restriction.
    Aucott SW; Donohue PK; Northington FJ
    J Perinatol; 2004 Jul; 24(7):435-40. PubMed ID: 15116139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.